Cargando…

Changes in Brain-Health Related Modifiable Risk Factors in Older Adults After One Year of COVID-19-Restrictions

BACKGROUND: The COVID-19 pandemic has major influence on lifestyle and mental health, which might affect brain-health and increase the risk of cognitive decline, particularly in older adults. We aimed to describe changes in modifiable risk factors related to brain-health in older adults after one ye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waterink, Lisa, Bakker, Els D., Visser, Leonie N. C., Mangialasche, Francesca, Kivipelto, Miia, Deckers, Kay, Köhler, Sebastian, Sikkes, Sietske A. M., Prins, Niels D., Scheltens, Philip, van der Flier, Wiesje M., Zwan, Marissa D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201112/ https://www.ncbi.nlm.nih.gov/pubmed/35722572 http://dx.doi.org/10.3389/fpsyt.2022.877460

Ejemplares similares

Everyday Functioning in a Community-Based Volunteer Population: Differences Between Participant- and Study Partner-Report
por: Verrijp, Merike, et al.
Publicado: (2022)

Experiences of and recommendations on clinical trial design in Alzheimer’s disease from the participant’s point of view: a mixed-methods study in two clinical trial centers in the Netherlands
por: Ottenhoff, Lois, et al.
Publicado: (2023)

Changes in Lifestyle, Behaviors, and Risk Factors for Cognitive Impairment in Older Persons During the First Wave of the Coronavirus Disease 2019 Pandemic in Finland: Results From the FINGER Study
por: Lehtisalo, Jenni, et al.
Publicado: (2021)

Dutch Brain Research Registry for study participant recruitment: Design and first results
por: Zwan, Marissa D., et al.
Publicado: (2021)

Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity
por: Jutten, Roos J., et al.
Publicado: (2021)

The Cognitive Online Self‐Test Amsterdam (COST‐A): Establishing norm scores in a community‐dwelling population
por: Visser, Leonie N.C., et al.
Publicado: (2021)

Steeper memory decline after COVID-19 lockdown measures
por: Bakker, Els D., et al.
Publicado: (2023)

Psychosocial Effects of Corona Measures on Patients With Dementia, Mild Cognitive Impairment and Subjective Cognitive Decline
por: van Maurik, Ingrid S., et al.
Publicado: (2020)

Advances in the prevention of Alzheimer's Disease
por: Sindi, Shireen, et al.
Publicado: (2015)

Pre‐amyloid stage of Alzheimer's disease in cognitively normal individuals
por: Tijms, Betty M., et al.
Publicado: (2018)

Screening for Mild Cognitive Impairment and Dementia with Automated, Anonymous Online and Telephone Cognitive Self-Tests
por: Van Mierlo, Lisa D., et al.
Publicado: (2017)

ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinics
por: Fruijtier, Agnetha D., et al.
Publicado: (2019)

Development and Usability of ADappt: Web-Based Tool to Support Clinicians, Patients, and Caregivers in the Diagnosis of Mild Cognitive Impairment and Alzheimer Disease
por: van Maurik, Ingrid S, et al.
Publicado: (2019)

Dementia prevention: current epidemiological evidence and future perspective
por: Mangialasche, Francesca, et al.
Publicado: (2012)

World-Wide FINGERS: An International Network of Linked Multidomain Trials
por: Mangialasche, Francesca, et al.
Publicado: (2021)

Communication about diagnosis, prognosis, and prevention in the memory clinic: perspectives of European memory clinic professionals
por: Hendriksen, Heleen M. A., et al.
Publicado: (2023)

Giving meaning to the scores of the Amsterdam instrumental activities of daily living questionnaire: a qualitative study
por: Dubbelman, Mark A., et al.
Publicado: (2022)

Editorial: Cognitive, Psychological, and Psychiatric Consequences of the Coronavirus (COVID-19) Pandemic in the Population of Older Persons With Cognitive Impairment, Dementia, and/or Neuropsychiatric Disorders
por: Palmer, Katie, et al.
Publicado: (2021)

Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults
por: ten Kate, Mara, et al.
Publicado: (2018)

Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer’s Disease, and Dementia: From FINGER to World-Wide FINGERS
por: Rosenberg, A., et al.
Publicado: (2019)

Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial
por: Fruijtier, Agnetha D., et al.
Publicado: (2022)

Microbleeds are associated with depressive symptoms in Alzheimer's disease
por: Leeuwis, Anna E., et al.
Publicado: (2017)

Web-Based Multidomain Lifestyle Programs for Brain Health: Comprehensive Overview and Meta-Analysis
por: Wesselman, Linda MP, et al.
Publicado: (2019)

Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging
por: Leijenaar, Jolien F., et al.
Publicado: (2017)

Dementia risk communication. A user manual for Brain Health Services—part 3 of 6
por: Visser, Leonie N. C., et al.
Publicado: (2021)

Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results
por: Slot, Rosalinde E. R., et al.
Publicado: (2018)

Amyloid-β Load Is Related to Worries, but Not to Severity of Cognitive Complaints in Individuals With Subjective Cognitive Decline: The SCIENCe Project
por: Verfaillie, Sander C. J., et al.
Publicado: (2019)

Identifying relevant outcomes in the progression of Alzheimer's disease; what do patients and care partners want to know about prognosis?
por: Mank, Arenda, et al.
Publicado: (2021)

Can novel therapeutics halt the amyloid cascade?
por: Prins, Niels D, et al.
Publicado: (2010)

Diagnostic impact of [(18)F]flutemetamol PET in early-onset dementia
por: Zwan, Marissa D., et al.
Publicado: (2017)

The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial
por: Prins, Niels D, et al.
Publicado: (2014)

Quantifying dementia prevention potential in the FINGER randomized controlled trial using the LIBRA prevention index
por: Deckers, Kay, et al.
Publicado: (2021)

Transitions: Experiences of younger persons recently diagnosed with Alzheimer-type dementia
por: Aspö, Malin, et al.
Publicado: (2023)

Dietary Patterns Are Related to Clinical Characteristics in Memory Clinic Patients with Subjective Cognitive Decline: The SCIENCe Project
por: Wesselman, Linda M. P., et al.
Publicado: (2019)

Amsterdam Dementia Cohort: Performing Research to Optimize Care
por: van der Flier, Wiesje M., et al.
Publicado: (2018)

Subjective cognitive decline and self‐reported sleep problems: The SCIENCe project
por: Exalto, Lieza G., et al.
Publicado: (2022)

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
por: de Wilde, Arno, et al.
Publicado: (2019)

Determinants of informal care time, distress, depression, and quality of life in care partners along the trajectory of Alzheimer's disease
por: Mank, Arenda, et al.
Publicado: (2023)

Personalized risk for clinical progression in cognitively normal subjects—the ABIDE project
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease
por: Benedictus, Marije R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mplbmn31hpqk6ofbjir2cor582